Header cover image

Bayer CropScience

Market Cap


Last Updated

2021/05/12 12:18 UTC

Data Sources

Company Financials

Executive Summary

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products in India. More Details


Earnings grew by 60.4% over the past year

Pays a reliable dividend of 1.64%

Risk Analysis

No risks detected for 506285 from our risk checks.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

Similar Companies

Share Price & News

How has Bayer CropScience's share price performed over time and what events caused price changes?

Latest Share Price and Events

Stable Share Price: 506285 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: 506285's weekly volatility (3%) has been stable over the past year.

Market Performance

7 Day Return




IN Chemicals


IN Market

1 Year Return




IN Chemicals


IN Market

Return vs Industry: 506285 underperformed the Indian Chemicals industry which returned 79.4% over the past year.

Return vs Market: 506285 underperformed the Indian Market which returned 68.6% over the past year.

Shareholder returns

7 Day2.7%1.7%1.5%
30 Day7.4%8.0%5.3%
90 Day-0.9%14.0%3.4%
1 Year24.8%22.3%78.6%77.1%67.5%65.0%
3 Year23.4%19.8%79.3%70.4%30.4%23.9%
5 Year43.3%38.1%191.6%171.7%91.5%76.7%

Long-Term Price Volatility Vs. Market

How volatile is Bayer CropScience's share price compared to the market and industry in the last 5 years?

Simply Wall St News


Is Bayer CropScience undervalued compared to its fair value and its price relative to the market?


Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: 506285 (₹5485.8) is trading above our estimate of fair value (₹4339.1)

Significantly Below Fair Value: 506285 is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: 506285 is poor value based on its PE Ratio (53.3x) compared to the Indian Chemicals industry average (19.4x).

PE vs Market: 506285 is poor value based on its PE Ratio (53.3x) compared to the Indian market (19.8x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 506285's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: 506285 is overvalued based on its PB Ratio (9.7x) compared to the IN Chemicals industry average (1.8x).

Future Growth

How is Bayer CropScience forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?


Forecasted Materials industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bayer CropScience has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Bayer CropScience performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 506285 has high quality earnings.

Growing Profit Margin: 506285's current net profit margins (11.6%) are higher than last year (9.8%).

Past Earnings Growth Analysis

Earnings Trend: 506285's earnings have grown by 9.8% per year over the past 5 years.

Accelerating Growth: 506285's earnings growth over the past year (60.4%) exceeds its 5-year average (9.8% per year).

Earnings vs Industry: 506285 earnings growth over the past year (60.4%) exceeded the Chemicals industry 9.5%.

Return on Equity

High ROE: 506285's Return on Equity (18.3%) is considered low.

Financial Health

How is Bayer CropScience's financial position?

Financial Position Analysis

Short Term Liabilities: 506285's short term assets (₹34.7B) exceed its short term liabilities (₹16.1B).

Long Term Liabilities: 506285's short term assets (₹34.7B) exceed its long term liabilities (₹1.1B).

Debt to Equity History and Analysis

Debt Level: 506285 is debt free.

Reducing Debt: 506285 had no debt 5 years ago.

Debt Coverage: 506285 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 506285 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet


What is Bayer CropScience current dividend yield, its reliability and sustainability?


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 506285's dividend (1.64%) is higher than the bottom 25% of dividend payers in the Indian market (0.4%).

High Dividend: 506285's dividend (1.64%) is low compared to the top 25% of dividend payers in the Indian market (1.68%).

Stability and Growth of Payments

Stable Dividend: 506285's dividends per share have been stable in the past 10 years.

Growing Dividend: 506285's dividend payments have increased over the past 10 years.

Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (24.3%), 506285's dividend payments are well covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Duraiswami Narain (57 yo)





Mr. Duraiswami Narain has been Vice Chairman, Managing Director and CEO of Bayer CropScience Limited since December 1, 2018 and as its Executive Director since October 23, 2018. Mr. Narain served as Vice P...

CEO Compensation Analysis

Compensation vs Market: Duraiswami's total compensation ($USD1.92M) is above average for companies of similar size in the Indian market ($USD650.85K).

Compensation vs Earnings: Duraiswami's compensation has increased by more than 20% in the past year.

Leadership Team

Experienced Management: 506285's management team is considered experienced (2.4 years average tenure).

Board Members

Experienced Board: 506285's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Bayer CropScience Limited's company bio, employee growth, exchange listings and data sources

Key Information

  • Name: Bayer CropScience Limited
  • Ticker: 506285
  • Exchange: BSE
  • Founded: 1958
  • Industry: Fertilizers and Agricultural Chemicals
  • Sector: Materials
  • Market Cap: ₹274.024b
  • Shares outstanding: 50.11m
  • Website:

Number of Employees


  • Bayer CropScience Limited
  • Bayer House
  • Central Avenue
  • Thane
  • Maharashtra
  • 400 607
  • India



Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products in India. It also provides pharmaceutical produ...

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/12 12:18
End of Day Share Price2021/05/12 00:00
Annual Earnings2020/03/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.